Related Experiment Video

Updated: May 17, 2026

Endoscopic Cholesteatoma Surgery
08:47

Endoscopic Cholesteatoma Surgery

Published on: January 19, 2022

Myeloperoxydase activity in the pathogenesis of cholesteatoma

Ozlem Celebi1, Mustafa Paksoy, Sedat Aydin

  • 1Rize Government Hospital, Rize, Turkey.

Abstract

Insights

Myeloperoxidase (MPO) activity is significantly elevated in patients with chronic otitis media (COM) and cholesteatoma, correlating with bone destruction. This finding may lead to new diagnostic approaches for cholesteatoma treatment.

Area of Science:

  • Otolaryngology
  • Immunohistochemistry
  • Pathology

Background:

  • Chronic otitis media (COM) with cholesteatoma is associated with significant bone destruction.
  • The role of myeloperoxidase (MPO) in this pathological process requires further elucidation.

Purpose of the Study:

  • To investigate the effect of MPO on bone destruction in COM patients with cholesteatoma.
  • To determine the relationship between MPO activity and bone erosion in these patients.

Main Methods:

  • Immuno-histochemical staining was used to assess MPO activity.
  • A study group of 51 COM patients with cholesteatoma and a control group of 30 patients were analyzed.

Main Results:

  • Significantly higher MPO levels were observed in the patient group compared to the control group (p = 0.001).
  • MPO activity correlated significantly with middle ear and mastoid bone erosion (p < 0.05), but not with dura bone destruction (p > 0.05).

Conclusions:

  • A significant correlation exists between MPO levels and bone destruction in COM with cholesteatoma.
  • Preoperative MPO level determination could offer valuable insights into bone erosion, potentially guiding cholesteatoma treatment strategies.